The main use of ADMET models, whether in silico or in vitro,tends to be molecule ‘profiling’; identifying compounds which are expected to have poor properties for a particular project. However, there are more uses beyond these basic profiling cases. ADMET models can be used to guide key decisions, informing chemical series selection or compound design.
To make decisions with confidence, both predictions and their uncertainties must be considered, and values compared against pre-defined success criteria. The relationship between compound structure and ADMET prediction should be considered and visualised, to guide any potential redesign of the molecules. This article discusses how to achieve these goals, including a showcase of practical examples.
M. D. Segall, E. Champness, O. Obrezanova, C. Leeding, Chemistry & Biodiversity, 2009, 6(11) pp. 2144-2151
Find out more
Visit the journal webpage to read this peer-reviewed article on ‘beyond profiling’.
INTERESTED IN DRUG OPTIMIZATION?
With its comprehensive suite of integrated software, StarDrop™ delivers best-in-class in silico technologies within a highly visual and user-friendly interface. StarDrop™ enables a seamless flow from the latest data through predictive modelling to decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the drug optimisation and discovery process.